U.S. Chamber Submits Comments on Medicare Drug Price Negotiation Program

The U.S. Chamber of Commerce Global Innovation Policy Center urges the Centers for Medicare and Medicaid Services to re-evaluate the approach taken in the Agency's Draft Guidance, which proposes to implement the second year of the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act.